These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1756 related articles for article (PubMed ID: 8433011)

  • 1. Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma.
    Shibata T; Pavel S; Smit NP; Mishima Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):222S-225S. PubMed ID: 8433011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-methylation of L-dopa in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes.
    Smit N; Tilgmann C; Karhunen T; Slingerland R; Ulmanen I; Westerhof W; Pavel S
    Pigment Cell Res; 1994 Dec; 7(6):403-8. PubMed ID: 7539130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
    Imokawa G; Mishima Y
    Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
    Imokawa G; Mishima Y
    Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
    Imokawa G; Mishima Y
    Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of melanogenesis intermediates.
    Pavel S
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):162S-165S. PubMed ID: 8433003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of three hamster melanoma variants--I. Tyrosinase activity and melanin content.
    Słomiński A; Scisłowski PW; Bomirski A
    Int J Biochem; 1984; 16(3):323-6. PubMed ID: 6421636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanin monomers within coated vesicles and premelanosomes in melanin synthesizing cells.
    Hatta S; Mishima Y; Ichihashi M; Ito S
    J Invest Dermatol; 1988 Aug; 91(2):181-4. PubMed ID: 3135338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with elevated tyrosinase activity.
    Bomirski A; Wrzołkowa T; Arendarczyk M; Bomirska M; Kuklinska E; Słominski A; Moellmann G
    J Invest Dermatol; 1987 Nov; 89(5):469-73. PubMed ID: 3117904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y; Jimbow K
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM
    Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble and particulate forms of rat catechol-O-methyltransferase distinguished by gel electrophoresis and immune fixation.
    Grossman MH; Creveling CR; Rybczynski R; Braverman M; Isersky C; Breakefield XO
    J Neurochem; 1985 Feb; 44(2):421-32. PubMed ID: 3880804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
    Nishioka K
    FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
    García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
    Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the melanogenic system in the eye of adult rodents.
    Benedito E; Jiménez-Cervantes C; Cubillana JD; Solano F; Lozano JA; García-Borrón JC
    Biochim Biophys Acta; 1995 Oct; 1252(2):217-24. PubMed ID: 7578226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 20. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.